Regeneron Pharmaceuticals Inc Earnings

The next earnings date for Regeneron Pharmaceuticals Inc is October 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Regeneron Pharmaceuticals Inc Earnings

Report DateEstimated Earnings Per Share
10/30/2025$9.65

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Regeneron Pharmaceuticals Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
07/30/2025Before Market------
04/30/2025Before Market$8.22-3.03%
01/31/2025Before Market$12.076.06%
10/31/2024Before Market$12.466.59%
08/01/2024Before Market$11.568.95%
05/02/2024Before Market$9.55-5.35%
02/02/2024Before Market$11.8610.53%
11/02/2023Before Market$11.598.12%
08/03/2023Before Market$10.244.07%
05/04/2023Before Market$10.095.54%
02/03/2023Before Market$12.5625.22%
11/03/2022Before Market$11.1417.51%
08/03/2022Before Market$9.7710.52%
05/04/2022Before Market$8.93-8.32%
02/04/2022Before Market$21.3216.19%
11/04/2021Before Market$14.3742.28%
08/05/2021Before Market$25.8047.18%
05/06/2021Before Market$9.899.89%
02/05/2021Before Market$9.5313.59%
11/05/2020Before Market$8.3617.09%
08/05/2020Before Market$7.1619.73%
05/05/2020Before Market$6.607.67%
02/06/2020Before Market$7.508.54%
11/05/2019Before Market$6.674.87%
08/06/2019Before Market$6.0211.28%
05/07/2019Before Market$4.45-18.65%
02/06/2019Before Market$6.8422.14%
11/06/2018Before Market$5.8714.43%
08/02/2018Before Market$5.4515.96%
05/03/2018Before Market$4.677.36%
02/08/2018Before Market$5.2315.45%
11/08/2017Before Market$3.993.64%
08/03/2017Before Market$4.1731.55%
05/04/2017Before Market$2.92-4.58%
02/09/2017Before Market$3.040.33%
11/04/2016Before Market$3.1315.50%
08/04/2016Before Market$2.826.42%
05/05/2016Before Market$2.57-0.39%
02/09/2016Before Market$2.83-15.77%
11/04/2015Before Market$3.478.44%
08/04/2015Before Market$2.894.33%
05/07/2015Before Market$2.887.46%
02/10/2015Before Market$2.79-1.06%
11/04/2014Before Market$2.52-1.95%
08/05/2014---$2.477.86%
05/08/2014---$2.262.73%
02/11/2014---$0.86-12.24%
11/05/2013---$1.2538.89%
08/06/2013---$0.79-10.23%
05/03/2013---$0.90-8.16%
02/14/2013---$1.2210.91%
10/24/2012---$1.7281.05%
07/25/2012---$0.70159.26%
04/26/2012---$0.16169.57%
02/13/2012---$-0.5410.00%
10/27/2011---$-0.6810.53%
07/28/2011---$-0.69-68.29%
05/03/2011---$-0.49-36.11%
02/17/2011---$-0.1746.88%
10/28/2010---$-0.41-20.59%
07/28/2010---$-0.3116.22%
04/29/2010---$-0.3822.45%
02/18/2010---$-0.46-35.29%
11/03/2009---$-0.0195.24%
08/04/2009---$-0.1932.14%
04/30/2009---$-0.2229.03%
02/26/2009---$-0.40-33.33%
11/04/2008---$-0.2715.63%
07/31/2008---$-0.2323.33%
05/01/2008---$-0.1553.13%
02/27/2008---$-0.1959.57%
11/06/2007---$-0.54-80.00%
08/01/2007---$-0.414.65%
05/02/2007---$-0.468.00%
03/01/2007---$-0.510.00%
11/06/2006---$-0.4814.29%
08/03/2006---$-0.4126.79%
05/03/2006---$-0.3640.98%
02/24/2006---$-0.5318.46%
11/03/2005---$-0.5211.86%
08/04/2005---$-0.3825.49%
04/28/2005---$-0.0775.00%
02/22/2005---$0.05113.89%
10/28/2004---$-0.2050.00%
07/26/2004---$-0.2613.33%
04/26/2004---$1.06330.43%
02/23/2004---$-0.3533.96%
10/29/2003---$-0.523.70%
08/01/2003---$-0.583.33%
05/05/2003---$-0.6820.00%
01/30/2003---$-0.814.71%
10/31/2002---$-0.753.85%
07/30/2002---$-0.69-7.81%
04/29/2002---$-0.586.45%
01/31/2002---$-0.65-4.84%
10/22/2001---$-0.4616.36%
07/31/2001---$-0.3434.62%
05/01/2001---$-0.3518.60%
01/25/2001---$-0.2332.35%
10/24/2000---$-0.0970.00%
07/27/2000---$-0.0838.46%
04/28/2000---$-0.23-91.67%
02/04/2000---$-0.0480.95%
10/28/1999---$-0.1620.00%
07/30/1999---$-0.250.00%
03/31/1999---$-0.29---
12/31/1998---$-0.18---
09/30/1998---$-0.05---
06/30/1998---$0.07---
03/31/1998---$-0.12---
08/01/1997---$-0.1623.81%
05/06/1997---$-0.2339.47%
02/05/1997Before Market$-0.323.03%
10/23/1996Before Market$-0.35-2.94%
07/29/1996Before Market$-0.3122.50%
05/03/1996Before Market$-0.352.78%
02/05/1996Before Market$-0.38-26.67%
11/14/1995Before Market$-0.3217.95%
08/01/1995Before Market$-0.228.33%
05/03/1995---$-0.2237.14%
02/13/1995---$-0.3023.08%
10/31/1994---$-0.2141.67%
08/03/1994---$-0.546.90%

More About Regeneron Pharmaceuticals Inc

Country
USA
Full Time Employees
15,182

Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.

Regeneron Pharmaceuticals Inc Earnings” Can Refer to the Regeneron Pharmaceuticals Inc Earnings Date

Some people say “Regeneron Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Regeneron Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Regeneron Pharmaceuticals Inc Stock on the Earnings Date

If you own Regeneron Pharmaceuticals Inc stock (REGN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Regeneron Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Regeneron Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Owning Regeneron Pharmaceuticals Inc Options on the Earnings Date

If you own Regeneron Pharmaceuticals Inc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

In addition, the extrinsic values of Regeneron Pharmaceuticals Inc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Regeneron Pharmaceuticals Inc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.

This makes sense considering that prices are often more volatile on earnings dates for Regeneron Pharmaceuticals Inc. That potential volatility is a key factor that affects the premium cost of owning options.

Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Regeneron Pharmaceuticals Inc options often go down. This is sometimes referred to as volatility crush.

Learning More Regeneron Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Regeneron Pharmaceuticals Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.